Table 2.
Patients with acromegaly | General population | High-risk group | |
---|---|---|---|
Number of patients/participants | 73 | 325 | 314 |
Males/females (%) | 19/81 | 15/85 | 15/85 |
Age (years) | 54 (47–60) | 54 (46–62) | 54 (48–62) |
BMI (kg/m2) | 30.1 (26.9–34.0) | 29.6 (26.5–33.9) | 30.5 (27.2–35.1) |
SBP (mmHg) | 135±19 | 137±24 | 143±23 |
DBP (mmHg) | 84±11 | 85±12 | 88±12 |
Newly diagnosed diabetes, n (%) | 27 (37.0) | 31 (9.5) | 77 (24.5) |
Isolated IFG, n (%) | 10 (13.7) | 36 (11.1) | 32 (10.2) |
Isolated IGT, n (%) | 4 (5.5) | 13 (4.0) | 32 (10.2) |
Combination of IFG+IGT, n (%) | 11 (15.1) | 11 (3.4) | 21 (6.7) |
ECMDs, n (%) | 25 (34.2) | 60 (18.5) | 85 (27.1) |
Normoglycaemia, n (%) | 21 (28.8) | 234 (72.0) | 152 (48.4) |
Data are given as absolute numbers (n) and percentage (%) or median (interquartile range). Groups were matched for gender, age and BMI. SBP, systolic blood pressure; DBP, diastolic blood pressure; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; ECMDs, early carbohydrate metabolism disorders.